On 26 November, Jan Stålemark, CEO of Mandometer AB, got all excited! Mandometer was awarded a 1 million SEK research grant from VINNOVA, Sweden´s Innovation Agency, to make Mandometer available to obese patients in primary care. The clinical Staff at Mando Group has already shown that it works.
Mando Group AB´s regular and appreciated course: Mando Academy started on Monday, 11 November. The neural engagement in eating and body weight regulation is followed by Mandometer theory and treatment, including clinical demonstrations and practical applications. The lectures are interactive; the teachers enjoy being interrupted by almost any question. And the students enjoy being certified after the course!
Mando Group Staff celebrated that the Medical Product Agency of Sweden has registered Mandometer as a medical device. Mandometer has already been cleared by the US Food and Drug Administration (FDA) for the treatment of eating disorders. Clearing a new medical device is the time consuming first step in making it possible for all in need to use the device.
Ioannis Ioakimidis met his new research colleagues from Greece, Spain, Switzerland and The Netherlands to start SPLENDID, the big research grant that he won in competition with more than 250 European researchers. The project started with two days of planning in Thessaloniki and aims at preventing body weight problems by developing mobile technologies for personalized behavioral health.
In fierce competition, Ioannis Ioakimidis, of Mando Group AB, has been awarded an EU-grant together with researchers in Greece and Holland and electronic engineers in Switzerland and Spain to develop methods for continuously monitoring eating behaviour and physical activity in children and adults. The grant aims at preventing people from becoming over- or underweight.